CN102253217A - 一种胶乳颗粒增强型中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 - Google Patents
一种胶乳颗粒增强型中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 Download PDFInfo
- Publication number
- CN102253217A CN102253217A CN2011100863695A CN201110086369A CN102253217A CN 102253217 A CN102253217 A CN 102253217A CN 2011100863695 A CN2011100863695 A CN 2011100863695A CN 201110086369 A CN201110086369 A CN 201110086369A CN 102253217 A CN102253217 A CN 102253217A
- Authority
- CN
- China
- Prior art keywords
- neutrophil gelatinase
- detection kit
- reagent
- associated lipocalin
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004816 latex Substances 0.000 title claims abstract description 27
- 229920000126 latex Polymers 0.000 title claims abstract description 27
- 238000001514 detection method Methods 0.000 title claims abstract description 18
- 239000002245 particle Substances 0.000 title claims abstract description 14
- 102000013382 Gelatinases Human genes 0.000 title claims abstract description 8
- 108010026132 Gelatinases Proteins 0.000 title claims abstract description 8
- 210000000440 neutrophil Anatomy 0.000 title claims abstract description 8
- 108010053156 lipid transfer protein Proteins 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 108010051335 Lipocalin-2 Proteins 0.000 claims description 50
- 102000013519 Lipocalin-2 Human genes 0.000 claims description 49
- 239000003153 chemical reaction reagent Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 11
- 238000013016 damping Methods 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 102000019298 Lipocalin Human genes 0.000 claims description 5
- 108050006654 Lipocalin Proteins 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 3
- 239000008118 PEG 6000 Substances 0.000 claims description 2
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 239000007983 Tris buffer Substances 0.000 claims description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
- 239000007853 buffer solution Substances 0.000 claims 1
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 9
- 210000002700 urine Anatomy 0.000 abstract description 5
- 210000002966 serum Anatomy 0.000 abstract description 4
- 210000002381 plasma Anatomy 0.000 abstract description 3
- 238000002835 absorbance Methods 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000002872 contrast media Substances 0.000 description 3
- 208000009304 Acute Kidney Injury Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 208000033626 Renal failure acute Diseases 0.000 description 2
- 201000011040 acute kidney failure Diseases 0.000 description 2
- 208000012998 acute renal failure Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000001776 Matrix metalloproteinase-9 Human genes 0.000 description 1
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000009692 acute damage Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- RPENMORRBUTCPR-UHFFFAOYSA-M sodium;1-hydroxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].ON1C(=O)CC(S([O-])(=O)=O)C1=O RPENMORRBUTCPR-UHFFFAOYSA-M 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
Images
Abstract
Description
干扰物 | 测定值(mg/L) | 偏差CV(%) |
样本+生理盐水 | 0.124 | - |
样本+VC(1000mg/L) | 0.119 | 3.7 |
样本+TBiL(740mg/L) | 0.123 | 5 |
样本+Hb(5.0g/L) | 0.129 | 4.0 |
样本+甘油三酯(33g/L) | 0.117 | 5.6 |
样本+肝素钠(200U/ml) | 0.121 | 2.2 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110086369 CN102253217B (zh) | 2011-04-07 | 2011-04-07 | 一种胶乳颗粒增强型中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110086369 CN102253217B (zh) | 2011-04-07 | 2011-04-07 | 一种胶乳颗粒增强型中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102253217A true CN102253217A (zh) | 2011-11-23 |
CN102253217B CN102253217B (zh) | 2013-08-07 |
Family
ID=44980594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110086369 Active CN102253217B (zh) | 2011-04-07 | 2011-04-07 | 一种胶乳颗粒增强型中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102253217B (zh) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102590524A (zh) * | 2011-12-30 | 2012-07-18 | 北京九强生物技术股份有限公司 | 中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 |
CN102628865A (zh) * | 2011-12-30 | 2012-08-08 | 北京九强生物技术股份有限公司 | 检测肌红蛋白含量的胶乳增强免疫比浊试剂盒 |
CN102650641A (zh) * | 2012-04-28 | 2012-08-29 | 上海北加生化试剂有限公司 | 增强纳米胶乳免疫比浊法检测补体Clq浓度的试剂盒及方法 |
CN102662061A (zh) * | 2012-04-17 | 2012-09-12 | 北京九强生物技术股份有限公司 | 胶乳增强免疫比浊法测定人甲胎蛋白含量的试剂盒 |
CN102662064A (zh) * | 2012-04-26 | 2012-09-12 | 苏州照康生物技术有限公司 | 检测中性粒细胞明胶酶相关脂质运载蛋白的免疫比浊试剂盒及其制备方法 |
CN102680712A (zh) * | 2012-06-18 | 2012-09-19 | 王钊 | 竞争法胶乳颗粒增强免疫比浊bnp检测试剂盒及其制备方法 |
CN102680713A (zh) * | 2012-06-18 | 2012-09-19 | 王钊 | 竞争法胶乳颗粒增强免疫比浊c肽检测试剂盒及制备方法 |
CN102775473A (zh) * | 2012-07-30 | 2012-11-14 | 重庆业为基生物科技有限公司 | 人中性粒细胞明胶酶相关脂质运载蛋白的b细胞表位肽段及其应用 |
CN102798709A (zh) * | 2012-08-17 | 2012-11-28 | 深圳市锦瑞电子有限公司 | 一种抗体偶联物及其方法 |
CN103175964A (zh) * | 2013-02-21 | 2013-06-26 | 武汉华美生物工程有限公司 | 神经元特异性烯醇化酶含量检测试剂盒及其制备方法 |
CN103308698A (zh) * | 2013-06-17 | 2013-09-18 | 北京北检·新创源生物技术有限公司 | 一种将含氨基的分子共价偶联至微球上的偶联方法 |
CN103954776A (zh) * | 2014-05-12 | 2014-07-30 | 华权高 | Ngal光激发化学发光检测试剂盒、其制备及使用方法 |
CN104198732A (zh) * | 2014-08-28 | 2014-12-10 | 宁波瑞源生物科技有限公司 | 一种中性粒细胞明胶酶相关脂质运载蛋白含量检测试剂盒 |
CN104215769A (zh) * | 2014-08-14 | 2014-12-17 | 上海睿康生物科技有限公司 | 一种乳胶增强免疫比浊法ngal检测试剂盒 |
CN104849473A (zh) * | 2015-05-02 | 2015-08-19 | 王贤俊 | 一种尿微量白蛋白检测试剂盒及其制备 |
CN104865386A (zh) * | 2015-05-08 | 2015-08-26 | 浙江蓝森生物科技有限公司 | 一种人体血清中中性粒细胞明胶酶相关性脂质运载蛋白含量定量测定方法、试剂及试剂盒 |
CN105301257A (zh) * | 2015-05-02 | 2016-02-03 | 王贤俊 | 一种尿微量白蛋白检测方法 |
CN102650641B9 (zh) * | 2012-04-28 | 2016-05-18 | 上海北加生化试剂有限公司 | 增强纳米胶乳免疫比浊法检测补体Clq浓度的试剂盒及方法 |
CN106483297A (zh) * | 2016-09-29 | 2017-03-08 | 浙江达美生物技术有限公司 | 中性粒细胞明胶酶相关脂质运载蛋白测定试剂及制备方法 |
CN106645762A (zh) * | 2016-12-27 | 2017-05-10 | 菲鹏生物股份有限公司 | 中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 |
CN106771152A (zh) * | 2017-01-20 | 2017-05-31 | 深圳市汇松科技发展有限公司 | 一种快速检测钙卫蛋白的试剂盒 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1791797A (zh) * | 2003-03-27 | 2006-06-21 | 儿童医院医疗中心 | 用于检测肾小管细胞损伤的早发的方法和试剂盒 |
CN101027556A (zh) * | 2004-06-07 | 2007-08-29 | 儿童医院医疗中心 | 肾脏疾病和损伤的早期检测方法 |
CN101163971A (zh) * | 2004-12-20 | 2008-04-16 | 免疫体公司 | 测定作为肾病诊断标记物的嗜中性粒细胞明胶酶相关性脂笼蛋白(ngal) |
WO2008061149A2 (en) * | 2006-11-14 | 2008-05-22 | Biosite Incorporated | Methods and compositions for diagnosis and prognosis of renal artery stenosis |
CN101421622A (zh) * | 2006-02-17 | 2009-04-29 | 儿童医学中心公司 | 作为癌症生物标志物的游离ngal |
CN101498732A (zh) * | 2008-02-03 | 2009-08-05 | 北京九强生物技术有限公司 | 一种改良的前白蛋白检测试剂盒 |
CN101566633A (zh) * | 2009-04-17 | 2009-10-28 | 武汉华美生物工程有限公司 | 一种诊断评价或测定癌症并预知所述疾病严重性的方法 |
CN101968492A (zh) * | 2010-10-29 | 2011-02-09 | 厦门大学附属中山医院 | 检测脂联素的颗粒增强免疫透射比浊试剂盒及其制备方法 |
-
2011
- 2011-04-07 CN CN 201110086369 patent/CN102253217B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1791797A (zh) * | 2003-03-27 | 2006-06-21 | 儿童医院医疗中心 | 用于检测肾小管细胞损伤的早发的方法和试剂盒 |
CN101027556A (zh) * | 2004-06-07 | 2007-08-29 | 儿童医院医疗中心 | 肾脏疾病和损伤的早期检测方法 |
CN101163971A (zh) * | 2004-12-20 | 2008-04-16 | 免疫体公司 | 测定作为肾病诊断标记物的嗜中性粒细胞明胶酶相关性脂笼蛋白(ngal) |
CN101421622A (zh) * | 2006-02-17 | 2009-04-29 | 儿童医学中心公司 | 作为癌症生物标志物的游离ngal |
WO2008061149A2 (en) * | 2006-11-14 | 2008-05-22 | Biosite Incorporated | Methods and compositions for diagnosis and prognosis of renal artery stenosis |
CN101498732A (zh) * | 2008-02-03 | 2009-08-05 | 北京九强生物技术有限公司 | 一种改良的前白蛋白检测试剂盒 |
CN101566633A (zh) * | 2009-04-17 | 2009-10-28 | 武汉华美生物工程有限公司 | 一种诊断评价或测定癌症并预知所述疾病严重性的方法 |
CN101968492A (zh) * | 2010-10-29 | 2011-02-09 | 厦门大学附属中山医院 | 检测脂联素的颗粒增强免疫透射比浊试剂盒及其制备方法 |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102628865A (zh) * | 2011-12-30 | 2012-08-08 | 北京九强生物技术股份有限公司 | 检测肌红蛋白含量的胶乳增强免疫比浊试剂盒 |
CN102590524B (zh) * | 2011-12-30 | 2016-01-06 | 北京九强生物技术股份有限公司 | 中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 |
CN102590524A (zh) * | 2011-12-30 | 2012-07-18 | 北京九强生物技术股份有限公司 | 中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 |
CN102628865B (zh) * | 2011-12-30 | 2014-07-16 | 北京九强生物技术股份有限公司 | 检测肌红蛋白含量的胶乳增强免疫比浊试剂盒 |
WO2013097606A1 (zh) * | 2011-12-30 | 2013-07-04 | 北京九强生物技术股份有限公司 | 中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 |
CN102662061B (zh) * | 2012-04-17 | 2014-06-18 | 北京九强生物技术股份有限公司 | 胶乳增强免疫比浊法测定人甲胎蛋白含量的试剂盒 |
CN102662061A (zh) * | 2012-04-17 | 2012-09-12 | 北京九强生物技术股份有限公司 | 胶乳增强免疫比浊法测定人甲胎蛋白含量的试剂盒 |
CN102662064A (zh) * | 2012-04-26 | 2012-09-12 | 苏州照康生物技术有限公司 | 检测中性粒细胞明胶酶相关脂质运载蛋白的免疫比浊试剂盒及其制备方法 |
CN102650641A (zh) * | 2012-04-28 | 2012-08-29 | 上海北加生化试剂有限公司 | 增强纳米胶乳免疫比浊法检测补体Clq浓度的试剂盒及方法 |
CN102650641B9 (zh) * | 2012-04-28 | 2016-05-18 | 上海北加生化试剂有限公司 | 增强纳米胶乳免疫比浊法检测补体Clq浓度的试剂盒及方法 |
CN102650641B (zh) * | 2012-04-28 | 2014-06-18 | 上海北加生化试剂有限公司 | 增强纳米胶乳免疫比浊法检测补体Clq浓度的试剂盒及方法 |
CN102680712A (zh) * | 2012-06-18 | 2012-09-19 | 王钊 | 竞争法胶乳颗粒增强免疫比浊bnp检测试剂盒及其制备方法 |
CN102680713B (zh) * | 2012-06-18 | 2014-07-23 | 王钊 | 竞争法胶乳颗粒增强免疫比浊c肽检测试剂盒及制备方法 |
CN102680713A (zh) * | 2012-06-18 | 2012-09-19 | 王钊 | 竞争法胶乳颗粒增强免疫比浊c肽检测试剂盒及制备方法 |
CN102775473A (zh) * | 2012-07-30 | 2012-11-14 | 重庆业为基生物科技有限公司 | 人中性粒细胞明胶酶相关脂质运载蛋白的b细胞表位肽段及其应用 |
CN102775473B (zh) * | 2012-07-30 | 2018-10-12 | 重庆业为基生物科技有限公司 | 人中性粒细胞明胶酶相关脂质运载蛋白的b细胞表位肽段及其应用 |
CN102798709A (zh) * | 2012-08-17 | 2012-11-28 | 深圳市锦瑞电子有限公司 | 一种抗体偶联物及其方法 |
CN102798709B (zh) * | 2012-08-17 | 2014-11-19 | 深圳市锦瑞电子有限公司 | 一种抗体偶联物及其方法 |
CN103175964A (zh) * | 2013-02-21 | 2013-06-26 | 武汉华美生物工程有限公司 | 神经元特异性烯醇化酶含量检测试剂盒及其制备方法 |
CN103175964B (zh) * | 2013-02-21 | 2015-08-26 | 武汉华美生物工程有限公司 | 神经元特异性烯醇化酶含量检测试剂盒及其制备方法 |
CN103308698A (zh) * | 2013-06-17 | 2013-09-18 | 北京北检·新创源生物技术有限公司 | 一种将含氨基的分子共价偶联至微球上的偶联方法 |
CN103308698B (zh) * | 2013-06-17 | 2015-04-29 | 北京北检·新创源生物技术有限公司 | 一种将含氨基的分子共价偶联至微球上的偶联方法 |
CN103954776A (zh) * | 2014-05-12 | 2014-07-30 | 华权高 | Ngal光激发化学发光检测试剂盒、其制备及使用方法 |
CN104215769A (zh) * | 2014-08-14 | 2014-12-17 | 上海睿康生物科技有限公司 | 一种乳胶增强免疫比浊法ngal检测试剂盒 |
CN104198732B (zh) * | 2014-08-28 | 2015-08-19 | 宁波瑞源生物科技有限公司 | 一种中性粒细胞明胶酶相关脂质运载蛋白含量检测试剂盒 |
CN104198732A (zh) * | 2014-08-28 | 2014-12-10 | 宁波瑞源生物科技有限公司 | 一种中性粒细胞明胶酶相关脂质运载蛋白含量检测试剂盒 |
CN104849473A (zh) * | 2015-05-02 | 2015-08-19 | 王贤俊 | 一种尿微量白蛋白检测试剂盒及其制备 |
CN105301257A (zh) * | 2015-05-02 | 2016-02-03 | 王贤俊 | 一种尿微量白蛋白检测方法 |
CN104865386A (zh) * | 2015-05-08 | 2015-08-26 | 浙江蓝森生物科技有限公司 | 一种人体血清中中性粒细胞明胶酶相关性脂质运载蛋白含量定量测定方法、试剂及试剂盒 |
CN106483297A (zh) * | 2016-09-29 | 2017-03-08 | 浙江达美生物技术有限公司 | 中性粒细胞明胶酶相关脂质运载蛋白测定试剂及制备方法 |
CN106645762A (zh) * | 2016-12-27 | 2017-05-10 | 菲鹏生物股份有限公司 | 中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 |
CN106645762B (zh) * | 2016-12-27 | 2018-10-30 | 菲鹏生物股份有限公司 | 中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 |
CN106771152A (zh) * | 2017-01-20 | 2017-05-31 | 深圳市汇松科技发展有限公司 | 一种快速检测钙卫蛋白的试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN102253217B (zh) | 2013-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102253217B (zh) | 一种胶乳颗粒增强型中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 | |
CN101377492B (zh) | 胱抑素c测定试剂盒 | |
CN102749454B (zh) | 一种全量程c反应蛋白胶体金免疫比浊检测试剂盒 | |
Manceau et al. | Fecal calprotectin in inflammatory bowel diseases: update and perspectives | |
Xenoulis et al. | Canine and feline pancreatic lipase immunoreactivity | |
CN103134934B (zh) | 可以同时检测尿液和血清样本中视黄醇结合蛋白的试剂盒 | |
CN102680698B (zh) | 中性粒细胞明胶酶相关脂质运载蛋白(ngal)测定试剂盒(胶乳增强免疫比浊法) | |
CN104849473A (zh) | 一种尿微量白蛋白检测试剂盒及其制备 | |
CN105158476A (zh) | 一种全量程c反应蛋白胶乳增强免疫比浊检测试剂盒 | |
CN102507918B (zh) | 抗环瓜氨酸肽抗体测定试剂盒 | |
Krzeminska et al. | Comparison of two methods for determination of NGAL levels in urine: ELISA and CMIA | |
CN102590497A (zh) | 胱氨酸蛋白酶抑制剂c检测试剂盒 | |
CN102243241A (zh) | 一种匀相溶胶颗粒型中性粒细胞明胶酶相关脂质运载蛋白测定试剂盒及其制备方法 | |
CN110376378A (zh) | 可用于肺癌诊断的标志物联合检测模型 | |
Helal et al. | Determination of lysozyme activity by a fluorescence technique in comparison with the classical turbidity assay | |
Goodison et al. | A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort | |
CN102662064A (zh) | 检测中性粒细胞明胶酶相关脂质运载蛋白的免疫比浊试剂盒及其制备方法 | |
Chen et al. | Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis | |
Medina-Rosas et al. | Utility of untimed single urine protein/creatinine ratio as a substitute for 24-h proteinuria for assessment of proteinuria in systemic lupus erythematosus | |
Flitcroft et al. | Early detection of kidney cancer using urinary proteins: a truly non‐invasive strategy | |
Kim et al. | Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis | |
CN109521200A (zh) | 一种同时检测血浆中多种成分含量的试剂盒、方法及其应用 | |
CN104820099B (zh) | 一种同时检测血浆中TPSⅡ、SSA、hs‑CRP、PCT和抵抗素含量的试剂盒及其应用 | |
CN107918020B (zh) | 中性粒细胞明胶酶相关脂质运载蛋白测定试剂盒 | |
CN103675299A (zh) | 一种用于检测尿液中纤维连接蛋白浓度的试剂盒及其方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 430223 B11 building, No. 818, hi tech medical center, hi tech Avenue, East Lake Development Zone, Wuhan, Hubei, 2 Patentee after: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Address before: 430223 Hubei city of Wuhan province East Lake Development Zone Road, University of Wuhan University of science and Technology Park building four Building No. 13 West Patentee before: Wuhan Life Origin Biotech Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Detection kit of latex particle enhanced neutrophil gelatinase-associated lipid transfer protein Effective date of registration: 20180612 Granted publication date: 20130807 Pledgee: Wuhan rural commercial bank Limited by Share Ltd Optics Valley branch Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Registration number: 2018420000024 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190620 Granted publication date: 20130807 Pledgee: Wuhan rural commercial bank Limited by Share Ltd Optics Valley branch Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Registration number: 2018420000024 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Detection kit of latex particle enhanced neutrophil gelatinase-associated lipid transfer protein Effective date of registration: 20190813 Granted publication date: 20130807 Pledgee: Wuhan rural commercial bank Limited by Share Ltd Optics Valley branch Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. Registration number: Y2019420000004 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201223 Granted publication date: 20130807 Pledgee: Guanggu Branch of Wuhan Rural Commercial Bank Co.,Ltd. Pledgor: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK Co.,Ltd. Registration number: Y2019420000004 |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 430000 1 / F, 2 / F and 3 / F, B11, hi tech medical device Park, 818 Gaoxin Avenue, Donghu Development Zone, Wuhan, Hubei Province Patentee after: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK Co.,Ltd. Address before: 2 / F, B11, Gaoke medical instrument Park, 818 Gaoxin Avenue, Donghu Development Zone, Wuhan, Hubei 430223 Patentee before: WUHAN LIFE ORIGIN BIOTECH JOINT STOCK Co.,Ltd. |